Skip to main content Skip to main navigation menu Skip to site footer

The role of brain-derived neurotrophic factor (BDNF) in cognitive functions

  • Dedi Silakarma ,
  • Anak Agung Raka Sudewi ,


Nerve growth factor (NGF) was uncovered in near beginning the 1950s which had a growth effect on sympathetic and sensory neurons. In the dorsal root neuron ganglion, the second member of a group of neurotrophic factors widely known as the brain-derived neurotrophic factor (BDNF) appeared. Like other members of the neurotrophin group, such as neurotrophin 3 (NT-3) and NT-4/5, it is explained to have trophic effects on peripheral and central neurons. Since BDNF purification in 1982 evidence of its involvement in development, physiology, and brain pathology demonstrated. BNDF is significant within the molecular mechanism of synapse plasticity regarding neuronal growth and cell survival. The initial step associated with the central nervous system depends on its adaption of synapse transmission, especially in the hippocampus and neocortex. Pathological intensities of the BDNF relationship and synapse plasticity affect sort of situations such as epilepsy and chronic pain sensitization, where BDNF applications can affect therapy in neurodegenerative diseases and neuropsychiatric diseases. BDNF plays a pivotal role in cognitive processes, affecting the advancement and brain structures’ motion. Predominantly in the hippocampus and prefrontal cortex, by modulating synaptic neurotransmission, it changes the plasticity and proliferation of neurons through regulation of neuronal migration processes such as differentiation, perseveration, neuronal modification and replacement of synaptic structures. BDNF also affects the development of dopaminergic, serotonergic, cholinergic and GABAergic. BDNF further causes rapid postsynaptic reactions in ion channels and N-Methyl D-Aspartate (NMDA) receptors. BDNF as a vital component in the normal functioning of the brain is one of the neurotrophins that contributes to the development, maintenance of function and healthy neuron cells and cynical plasticity.


  1. Notaras, Hill & Buuse, 2015. A role of BDNF gene Val66Met polymorphism in schizophrenia a comprehensive review. Neuroscience and behavioral review, Issue 51, pp. 15-30.
  2. Binder, D.K., Scharfman, H.E. 2004. Brain-derived Neurotrophic Factor. NIH Public Access. 22(3) 123-131.
  3. Vaughan, S. et al. 2014. The effect of multimodal exercise on cognitive and physical functioning and brain-derived neurotrophic factor in older women; a randomized controlled trial. Age and Ageing 43:623-629.
  4. Mowla, et al., 2011. Biosynthesis and post-transitional process of the precursor to brain-derived neurotrophic factor. J.Biol, Volume 16, pp. 50-54.
  5. Shimada, H. et al. 2014. A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly. Frontier in Aging Neuroscience Vol 6, 69-1
  6. Nettiksimons, J. et al. 2014. The Association between Serum Brain-Derived Neurotrophic Factor, Potential Confounders, and Cognitive Decline: A Longitudinal Study. PLOS ONE. Vol 9, Issue 3-e91339
  7. Adachi, N., Numakawa, T., Richards, M., Kunugi, H. and Nakajima, S. (2014). New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases. World Journal of Biological Chemistry, 5(4), p.409.
  8. Bathina, S. and Das, U. (2015). Brain-derived neurotrophic factor and its clinical implications. Archives of Medical Science, 6, pp.1164-1178.
  9. Lu, B., Nagappan, G. and Lu, Y. (2014). BDNF and Synaptic Plasticity, Cognitive Function, and Dysfunction. Neurotrophic Factors, pp.223-250.
  10. Riffault, B., Kourdougli, N., Dumon, C., Ferrand, N., Buhler, E., Schaller, F., Chambon, C., Rivera, C., Gaiarsa, J., and Porcher, C. (2016). Pro-Brain Derived Neurotrophic Factor (proBDNF)-Mediated p75NTR Activation Promotes Depolarizing Actions of GABA and Increases Susceptibility to Epileptic Seizures. Cerebral Cortex, 28(2), pp.510-527.
  11. Travaglia, A. and La Mendola, D. (2016). Zinc Interactions With Brain-Derived Neurotrophic Factor and Related Peptide Fragments.
  12. Korley, F., Diaz-Arrastia, R., Wu, A., Yue, J., Manley, G., Sair, H., Van Eyk, J., Everett, A., Okonkwo, D., Valadka, A., Gordon, W., Maas, A., Mukherjee, P., Yuh, E., Lingsma, H., Puccio, A. and Schnyer, D. (2016). Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury. Journal of Neurotrauma, 33(2), pp.215-225.
  13. Failla, M., Conley, Y. and Wagner, A. (2015). Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality. Neurorehabilitation and Neural Repair, 30(1), pp.83-93.
  14. Sidhu, M., Thompson, P., Wandschneider, B., Foulkes, A., de Tisi, J., Stretton, J., Perona, M., Thom, M., Bonelli, S., Burdett, J., Williams, E., Duncan, J. and Matarin, M. (2018). The impact of brain-derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy. CNS Neuroscience & Therapeutics.
  15. Piepmeier, A. and Etnier, J. (2015). Brain-derived neurotrophic factor (BDNF) as a potential mechanism of the effects of acute exercise on cognitive performance.
  16. Song, J., Yu, J. and Tan, L. (2014). Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy. Molecular Neurobiology, 52(3), pp.1477-1493.
  17. Budni, J., Bellettini-Santos, T., Mina, F., Lima Garcez, M. and Ioppi Zugno, A. (2015). The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease.
  18. Reinhart, V., Bove, S., Volfson, D., Lewis, D., Kleiman, R. and Lanz, T. (2015). Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
  19. Rakofsky, J., Ressler, K. and Dunlop, B. (2011). BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Molecular Psychiatry, 17(1), pp.22-35.
  20. Pollock, K., Dahlenburg, H., Nelson, H., Fink, K., Cary, W., Hendrix, K., Annett, G., Torrest, A., Deng, P., Gutierrez, J., Nacey, C., Pepper, K., Kalomoiris, S., Anderson, J., McGee, J., Gruenloh, W., Fury, B., Bauer, G., Duffy, A., Tempkin, T., Wheelock, V. and Nolta, J. (2016). Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Molecular Therapy, 24(5), pp.965-977.
  21. Nijs, J., Meeus, M., Versijpt, J., Moens, M., Bos, I., Knaepen, K. and Meeusen, R. (2014). Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?. Expert Opinion on Therapeutic Targets, 19(4), pp.565-576.

How to Cite

Silakarma, D., & Sudewi, A. A. R. (2019). The role of brain-derived neurotrophic factor (BDNF) in cognitive functions. Bali Medical Journal, 8(2), 518–525.




Search Panel

Dedi Silakarma
Google Scholar
BMJ Journal

Anak Agung Raka Sudewi
Google Scholar
BMJ Journal